Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Fougera, a division of Nycomed US, has announced that the FDA has approved its clotrimazole cream USP 1%.
Subscribe to our email newsletter
The generic formulation compares to Taro’s referenced listed drug and is available in three sizes: 15g tubes, 30g tubes and 45g tubes.
David Klaum, senior vice president and general manager of Fougera, said: “The approval of clotrimazole cream is another illustration of Fougera’s robust product pipeline. With each product approval, Fougera reaffirms its commitment to providing safe, effective and affordable options to health care providers and their patients.”